Stay updated on AMG 397 in Hematological Malignancies Clinical Trial

Sign up to get notified when there's something new on the AMG 397 in Hematological Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AMG 397 in Hematological Malignancies Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    10%
    Check dated 2025-10-05T10:22:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Update page revision from v3.0.2 to v3.1.0, indicating a newer release/version tag.
    Difference
    0.3%
    Check dated 2025-09-28T03:19:40.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.6%
    Check dated 2025-09-13T17:44:21.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.6%
    Check dated 2025-09-06T15:31:17.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    34%
    Check dated 2025-08-30T12:15:38.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:48:27.000Z thumbnail image

Stay in the know with updates to AMG 397 in Hematological Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AMG 397 in Hematological Malignancies Clinical Trial page.